The Global Infant Bifidobacterium Powder Market was valued at USD 104 Million in 2023 and is projected to reach USD 139.30 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.30% during the forecast period (2024-2032). This growth is being driven by increasing parental awareness of infant microbiome health, rising demand for preventive healthcare solutions, and expanding applications in infant formula and dietary supplements worldwide.

As pediatric nutrition science advances, leading probiotic companies are developing targeted bifidobacterium strains to support infant immunity, digestion and overall development. Here we examine the Top 10 Companies in the Infant Bifidobacterium Powder Industry—innovators shaping the future of pediatric probiotic formulations through clinical research and product innovation.

---

🔟 1. DuPont Nutrition & Biosciences

Headquarters: Wilmington, Delaware, USA
Key Offering: HOWARU® Infant Probiotics

DuPont leads the market with its clinically validated probiotic strains developed specifically for infant health. Their Bifidobacterium lactis HN019 demonstrates 94% survival through digestive transit in clinical studies.

Research Highlights:

• 12 peer-reviewed clinical studies in infants
• Strains shown to reduce infant crying time by 50% in colic trials
• Global distribution network serving 80+ countries

Download FREE Sample Report: Infant Bifidobacterium Powder Market – View in Detailed Research Report

---

9️⃣ 2. Chr. Hansen Holding A/S

Headquarters: Hørsholm, Denmark
Key Offering: BB-12® Bifidobacterium strain

Chr. Hansen’s BB-12® is the world’s most documented infant probiotic strain, backed by over 180 scientific publications including 25 clinical trials in pediatric populations.

Research Highlights:

• Proven to reduce antibiotic-associated diarrhea by 65% in infants
• 98% survival in powder formulations at 12 months

---

8️⃣ 3. Lallemand Health Solutions

Headquarters: Montreal, Canada
Key Offering: ProbioKid® range

Lallemand specializes in high-potency probiotic blends with CFU counts up to 300 billion per gram, using proprietary microencapsulation for optimal stability.

Research Highlights:

• 2-year ambient temperature stability
• Dairy-free, allergen-free formulations

---

7️⃣ 4. BioGaia AB

Headquarters: Stockholm, Sweden
Key Offering: Protectis® Baby

BioGaia focuses exclusively on pediatric probiotics, with products available in over 100 countries through partnerships with major infant formula brands.

Research Highlights:

• Patented straw delivery system ensures precise dosing
• Clinically shown to reduce NEC risk in preemies

Download FREE Sample Report: Infant Bifidobacterium Powder Market – View in Detailed Research Report

---

6️⃣ 5. Probi AB

Headquarters: Lund, Sweden
Key Offering: Lactobacillus & Bifidobacterium blends

Probi develops synergistic probiotic combinations specifically for infant health applications, with particular focus on preterm infant care.

Research Highlights:

• Hospital-grade formulations for NICU use
• Strain-specific dosing protocols

---

5️⃣ 6. Biosearch Life

Headquarters: Granada, Spain
Key Offering: HMO-compatible strains

Biosearch specializes in bifidobacterium strains that naturally thrive with human milk oligosaccharides, mimicking breastfed infant microbiomes.

Research Highlights:

• Strains isolated from breastfed infant guts
• Superior intestinal adhesion properties

---

4️⃣ 7. Morinaga Milk Industry

Headquarters: Tokyo, Japan
Key Offering: Bifidobacterium longum BB536

Morinaga’s flagship strain BB536 holds 60% market share in Japan’s infant probiotic sector, with over 50 years of documented safe use.

Research Highlights:

• Heat-stable up to 40°C for 4 weeks
• Reduces atopic dermatitis risk by 33%

---

3️⃣ 8. SYNBIO TECH INC.

Headquarters: Taipei, Taiwan
Key Offering: AI-selected strains

SYNBIO TECH applies machine learning to identify novel infant-specific bifidobacterium strains with enhanced functionality from their proprietary culture collection.

Research Highlights:

• AI-driven strain selection platform
• Customized probiotic solutions

---

2️⃣ 9. UAS Laboratories (Now part of Chr. Hansen)

Headquarters: Madison, Wisconsin, USA
Key Offering: Oxygen-tolerant strains

UAS Labs developed specialized bifidobacterium strains with enhanced oxygen resistance, improving stability during manufacturing and storage.

Research Highlights:

• Patented cryoprotectant technology
• 3-year guaranteed stability

---

1️⃣ 10. Bioflag Biotechnology

Headquarters: Guangzhou, China
Key Offering: High-CFU powders

Bioflag is China’s largest infant probiotic supplier, with GMP-certified facilities producing powders at 200-300 billion CFU/g concentrations.

Research Highlights:

• Halal and kosher certified options
• Specialized for Asian infant microbiomes

Get Full Report Here: Infant Bifidobacterium Powder Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Infant Probiotics Is Strain-Specific

The infant bifidobacterium market is evolving from generic probiotics to precision formulations targeting specific health outcomes, with growing emphasis on clinically validated strain-specific benefits.

📈 Key Trends Shaping the Market:

• Microbiome mapping enabling personalized probiotic regimens
• Combination products with prebiotics and postbiotics
• Clean-label and organic formulations gaining share
• Emerging markets accounting for 60% of new growth

Get Full Report Here: Infant Bifidobacterium Powder Market – View in Detailed Research Report

The companies profiled above are driving scientific advancement in pediatric gut health through rigorous research and innovative product development.